Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is a Chinese company that is engaged in the manufacture and sale of a wide range of neutraceutical products. Sunwin’s product lines include zero-calorie all natural Stevia sweeteners, traditional Chinese medicines, as well as veterinary medicines and animal feeds prepared from 100% organic herbal ingredients. Sunwin has built an integrated global organization with the sourcing and production capabilities to satisfy the needs of global consumers. For further information, visit the company website at: www.sunwininternational.com.
- 17 years ago
QualityStocks
Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…
-
QualityStocksNewsBreaks – Brand Engagement Network Inc. (NASDAQ: BNAI) Reports Warrant Exercises, Debt Conversion, and Public Warrants Update
Brand Engagement Network Inc. (NASDAQ: BNAI) announced on Wednesday that it generated approximately $1.46 million…
-
Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape
The World Health Organization’s recent recognition of rare diseases as a global health priority underscores…